Regen Report https://validator.w3.org/feed/docs/rss2.html ENCell Receives FDA Orphan Drug for DMD Stem Cell Therapy Innovacell Seeks $92M in Tokyo IPO to Advance Stem Cell Therapy Development Keck Medicine of USC Starting Parkinson’s Stem Cell Therapy Trial Homepage Excellthera’s Blood Stem Cell Therapy Nabs NUB Status 1 in Germany BioRestorative Completes Enrollment in Phase 2 Stem Cell Trial for Chronic Lumbar Disc Disease AAOS Launches New Orthobiologics Registry to Improve Knee Osteoarthritis Research GWOXI Files FDA Drug Master File for Adipose-Derived Stem Cell Bank Bracco Enters Cell Therapy Manufacturing with Cell Selection and Activation Technologies Medipost to Launch Phase 3 of CARTISTEM, its Cord Blood Stem Cell Therapy, for Knee Osteoarthritis Singapore’s EUDA Launching Stem Cell Clinic in Shenzen, Upgrading Manufacturing Platform for iPSC and Immunotherapy Johnson & Johnson Invests $1 Billion in Next-Gen Cell Therapy Manufacturing in Pennsylvania Arizona Pushes New Stem Cell Therapy Bill Multiply Labs Nabs Partnership with AstraZeneca to Explore Robotic Automation in Cell Therapy Production Cellares Teams Up with Stanford to Automate Gene-Edited Stem Cell Therapy Manufacturing NextCell Reports Positive 7-Year Data for its Stem Cell Candidate, ProTrans, for Type 1 Diabetes FibroBiologics Files Patent for New Fibroblast-Derived Platform for Orthopedic Indications Lineage Cell Therapeutics Receives Gene-Edited Stem Cell Line for Immune System Compatibility Studies FDA Approves StemCyte’s Expanded Access Cord Blood Therapy Program for Long COVID Pluristyx and Solesis Release New 3D Stem Cell Transfection Kit to Improve Efficiency and Reduce Toxicity Cellino and Polyphron Teaming Up to Scale Personalized Tissue Manufacturing Derived from iPSCs Aspect Biosystems Acquires Novo Nordisk’s Diabetes Stem Cell Therapy Tech REPROCELL Launches StemEdit: AI-Designed Gene Editing System and iPSC Product Lines for Clinical Use Pluri Helping Placenta-Derived Collagen Company Scale Up Production in Europe BlueRock Cell Therapeutics Receives FDA Orphan Drug for its Ocular Stem Cell Therapy, OpCT-001 Cytora Therapeutics Teams Up with Made Scientific and Zeo ScientifiX to Launch Stem Cell Therapy for Diabetic Foot Ulcers in the US Longeveron Nabs Patent for Stem Cell Testing Techniques in Japan Cyto-Facto to Manufacture Steminent’s Stem Cell Therapy for Spinocerebellar Ataxia, Seeking Conditional Approval in Japan China’s ElpasBio Chooses Fosun Kairos to Commercialize AlloJoin, it’s Stem Cell Therapy for Knee Osteoarthritis Japan Approves JTEC’s Cartilage Cell Therapy for Knee Osteoarthritis, Now Covered by Insurance Study Finds Bone Marrow-Derived Stem Cells No Better Than Placebo for Chronic Low Back Pain Thermo Fisher and NVIDIA Partnering on AI-Driven Lab Automation Trailhead Biosystems Secures Additional $20 Million to Develop Induced Pluripotent Stem Cells (iPSCs) Mesoblast Gets Good FDA Feedback on its Stem Cell Therapy for Back Pain, Rexlemestrocel-L, Progressing Towards BLA Chinese Phase 1 Parkinson’s Stem Cell Trial Reportedly Showing Promise Axol Bioscience Secures $2.8M to Develop iPSC Models New Neural Cell Therapy Company, Oryon Cell Therapies, Emerges Focused on Neurodegenerative Conditions Cellistic Unveils New Induced Pluripotent Stem Cell Manufacturing Platforms for Cancer and Regenerative Therapies Dark Horse Consulting Acquires Bruder Consulting, Launches New Regenerative Medicine Division CellFiber Launches GMP-Compliant Extruder for Advanced Cell Therapy Manufacturing MEDIPOST Files IND for Phase 3 of Umbilical Cord Blood Stem Cell Product, Cartistem, in USA for Knee Osteoarthritis Iowa Attorney General Wins $1 Million Judgement Against “Scam Stem Cell Treatment Company” Wyoming Unveils “Stem Cell Freedom Act” to Allow Certain Non-FDA-approved Stem Cell Therapies UC Irvine Awarded $12 Million for First Human Trial of Stem Cell Therapy in Huntington’s Disease StimLabs Receives FDA Approval for First Umbilical Cord-Derived Wound Sheet, Theracor Xtant Medical Launches New Synthetic Bone Graft, nanOss Strata, for Enhanced Healing BlueRock Therapeutics’ Cell Therapy for Parkinson’s Gains Special Designation in Japan Hope Biosciences Reports Positive Phase II Results for Parkinson’s Stem Cell Therapy New Startup iOrganBio Launches with $2M for AI-Based Cell Manufacturing Platform, CellForge™ Chinese Study Reports Intranasal Muse Stem Cells Show Potential for Parkinson’s Treatment